000952 logo

Hubei Guangji Pharmaceutical Co., Ltd. Stock Price

SZSE:000952 Community·CN¥2.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

000952 Share Price Performance

CN¥6.29
0.24 (3.97%)
CN¥6.29
0.24 (3.97%)
Price CN¥6.29

000952 Community Narratives

There are no narratives available yet.

Recent 000952 News & Updates

Subdued Growth No Barrier To Hubei Guangji Pharmaceutical Co., Ltd.'s (SZSE:000952) Price

Oct 28
Subdued Growth No Barrier To Hubei Guangji Pharmaceutical Co., Ltd.'s (SZSE:000952) Price

Hubei Guangji Pharmaceutical Co., Ltd. Key Details

CN¥626.7m

Revenue

CN¥491.0m

Cost of Revenue

CN¥135.7m

Gross Profit

CN¥399.8m

Other Expenses

-CN¥264.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 27, 2025
Earnings per share (EPS)
-0.76
Gross Margin
21.65%
Net Profit Margin
-42.15%
Debt/Equity Ratio
89.6%

Hubei Guangji Pharmaceutical Co., Ltd. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Slightly overvalued with imperfect balance sheet.

1 Risk
0 Rewards

About 000952

Founded
1969
Employees
1398
CEO
n/a
WebsiteView website
www.guangjipharm.com

Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations in China. The company also exports its products to approximately 30 countries and regions worldwide. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Chinese Market Performance

  • 7 Days: 1.8%
  • 3 Months: 18.3%
  • 1 Year: 24.1%
  • Year to Date: 26.2%
The Industrials sector has led the market, which has gained 1.8%. In the last year, the market has climbed 24%. Earnings are forecast to grow by 27% annually. Market details ›